1. Sparling PF. Biology of Neisseria gonorrhoeae. In : Sexually Transmitted Diseases, Holmes KK, Sparling PF, Stamm WE et al. 4th ed., New York, USA: McGraw Hill Professional, 2007. 2. Cheville NF. Ultrastructural Pathology: The Comparative Cellular Basis of Disease. Willey-Blackwell, 2009 3. Stein DC, LeVan A, Hardy B et al. Expression of Opacity Proteins Interferes with the Transmigration of Neisseria gonorrhoeae across Polarized Epithelial Cells. PLoS One. 2015 Aug 5;10(8):e0134342. doi: 10.1371/journal.pone.0134342. eCollection 2015. 4. Edwards JL, Apicella MA. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin Microbiol Rev. 2004 Oct;17(4):965-81 5. Łaniewski P, Gomez A, Hire G at al. Human Three-Dimensional Endometrial Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae. Infect Immun. 2017 Feb 23;85(3). pii: e01049-16. doi: 10.1128/IAI.01049-16. Print 2017 Mar. 31 6. Sexually transmitted bacterial pathogens. In : Sexually Transmitted Diseases, Holmes KK, Sparling PF, Stamm WE et al. 4th ed., New York, USA: McGraw Hill Professional, 2007. 7. WHO Report on global sexually transmitted infection surveillance 2018. p 10. https://www.who.int/reproductivehealth/publications/stis-surveillance-2018/en/ 8. WHO Guidelines for the Treatment of Neisseria gonorrhoeae 2018. ISBN: 978-92-4- 156569-1. p 10. https://www.who.int/reproductivehealth/publications/rtis/gonorrhoea-treatmentguidelines/en/ 9. European Centre for Disease Prevention and Control. Surveillance Report. Gonorrhoea Annual Epidemiological Report for 2017 https://www.ecdc.europa.eu/sites/default/files/documents/gonorrhoea-annual-epidemiologicalreport-2017.pdf 10. Sexually Transmitted Disease Surveillance 2018, CDC, https://www.cdc.gov/std/stats18/gonorrhea.htm8 11. Unemo M, Seifert HS, Hook EW 3rd et al. Gonorrhoea. Nat Rev Dis Primers. 2019 Nov 21;5(1):79. doi: 10.1038/s41572-019-0128-6. 12. Comninos NB, Garton L, Guy R et al. Increases in pharyngeal Neisseria gonorrhoeae positivity in men who have sex with men, 2011-2015: observational study. Sex Transm Infect. 2019 Oct 17. pii: sextrans-2019-054107. doi: 10.1136 13. Dave J, Paul J, Pasvol TJ et al. Ethnically diverse urban transmission networks of Neisseria gonorrhoeae without evidence of HIV serosorting. Sex Transm Infect. 2019 Oct 29. doi: 10.1136/sextrans-2019-054025. 14. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и заболеваниями кожи за 2017-2018 годы (статистические материалы). Москва. 2019. 208 с. РИО: ФГБУ «ЦНИИОИЗ» Минздрава России. 15. Кубанова А. А., Мелехина Л. Е., Кубанов А. А. Основные задачи развития дерматовенерологической помощи населению Российской Федерации на период до 2024 года. Результаты деятельности медицинских организаций по оказанию дерматовенерологической помощи населению Российской Федерации в 2017 году. Вестник дерматологии и венерологии. 2018;94(5):9–25. https://doi.org/10.25208/0042-4609-2018-945- 9-25 16. Кубанова А. А., Кубанов А. А., Мелехина Л. Е. Динамика изменений интенсивных показателей заболеваемости инфекций, передаваемым половым путем, в оценке эпидемиологического процесса и состояния здоровья населения Российской Федерации за 32 2006–2016 годы. Вестник дерматологии и венерологии. 2018;94(1):27-37. https://doi.org/10.25208/0042-4609-2018-94-1-27-37 17. Потекаев Н.Н., Кисина В.И., Гущин А.Е., Фриго Н.В., Новожилова О.Л. Ходырева Л.А. Современные проблемы по организации выявления и регистрации гонококковой инфекции в Москве. Клиническая дерматология и венерология. – 2019. – T18. - №6. – с 668- 674. 18. Alexander S. The challenges of detecting gonorrhea and chlamydia in rectal and pharyngeal sites: could we, should we, be doing more? Sex Trans Infect 2009;85:159–60. 19. Charlotte KK, Janice KC, William W et al. Prevalence of Rectal, Urethral, and Pharyngeal Chlamydia and Gonorrhea Detected in 2 Clinical Settings among Men Who Have Sex with Men: San Francisco, California, 2003. Clinical Infectious Diseases 2005;41:67–74. 10.1086/430704 20. American academy of Pediatrics. Sexually Transmitted Infections. Red Book®, editor Kimberly DW, 31st Edition, 2018, AAP Point-of-Care-Solutions. p.821-823 21. Jain N. Sexually transmitted diseases in the pediatric patient BCMJ, vol. 46 , No. 3 , April 2004 , Pages 133-138 22. Дарвилл Т. Глава 245: Гонококковая инфекция. Часть XVIII Инфекционные болезни. В книге: Педиатрия по Нельсону, Изд-во: МИА, 2009 г, т.3, стр.405-413 23. Bleich AT, Sheffield JS, Wendel GD Jr, Sigman A, Cunningham FG. Disseminated gonococcal infection in women. Obstet Gynecol 2012;119:597-602. 24. O’Brien JP, Goldenberg DL, Rice PA. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine 1983;62:395-406. 25. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In Holmes KK, Sparling PF, et al (eds.), Sexually Transmitted Diseases 4th ed. New York, NY. McGraw Hill 2008; 627- 45. 26. Fifer H, Saunders J, Soni S et al. 2019 British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae. https://www.bashhguidelines.org/media/1208/gc-2019.pdf 27. Гонококковая инфекция. Ведение больных: Рекомендации для врачей / Е. В. Соколовский, А. М. Савичева, В. И. Кисина и др. - СПб. : Фолиант, 2008. - 128 с. 28. Инфекции, передаваемые половым путем. Кисина В.И., Гущин А.Е., Забиров К.И. М., ГЭОТАР-Медиа, 2020 г. с 144 29. Кисина В.И. Урогенитальные инфекции, передаваемые половым путем, у детей: клинические аспекты, диагностика и лечение. Лечащий врач №5, 2004 г 33 30. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med 1996;72:422-6. 31. Barlow D, Phillips I. Gonorrhoea in women: diagnostic, clinical and laboratory aspects. Lancet 1978;1:761-4. 32. Taylor SN, DiCarlo RP, Martin DH. Comparison of methylene blue/gentian violet stain to Gram’s stain for the rapid diagnosis of gonococcal urethritis in men. Sex Trans Dis 2011;38:995-6. 33. Cuschieri K, Shepherd J, Graham C et al. Factors That Influence Confirmation of Neisseria gonorrhoeae Positivity by Molecular Methods. J Clin Microbiol. 2019 May 24;57(6). pii: e02068- 18. doi: 10.1128/JCM.02068-18. Print 2019 Jun. 34. Venter JME, Mahlangu PM, Müller EE et al. Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens. BMC Infect Dis. 2019 Jan 3;19(1):6. doi: 10.1186/s12879-018-3629-0. 35. Wind CM, de Vries HJ, Schim van der Loeff MF et al. Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture. J Clin Microbiol. 2015 Jun;53(6):1884-90. doi: 10.1128/JCM.00369-15. Epub 2015 Apr 1. 36. Harding-Esch EM, Fuller SS, Chow S et al. Diagnostic accuracy of a prototype rapid chlamydia and gonorrhea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation. Clin Microbiol Infect. 2019 Mar;25(3):380.e1-380.e7. doi: 10.1016/j.cmi.2018.06.003. Epub 2018 Jun 12. 37. Van der Pol B, Ferrero DV, Buck-Barrington L, Hook EW 3rd, Lenderman C, Quinn TC, et al. Multicenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical and male urethral swabs. J Clin Microbiol 2001;39:1008-16. 38. Association of Public Health Laboratories. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert consultation meeting summary report; January 13- 15, 2009; Atlanta, GA. Silver Spring, MD: Association of Public Health Laboratories; 2009. (http://www.aphl.org/aphlprograms/infectious/std/documents/ctgclabguidelinesmeetingre port.pdf) (accessed 30 October 2012). 39. Smith DW, Tapsall JW, Lum G. Guidelines for the use and interpretation of nucleic acid detection tests for Neisseria gonorrhoeae in Australia: a position paper on behalf of the Public Health Laboratory Network. Commun Dis Intell 2005;29:358-65. 40. Rönn MM, Mc Grath-Lone L, Davies B Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal 34 specimens relative to patient infection status: a systematic review. BMJ Open. 2019 Jan 17;9(1):e022510. doi: 10.1136/bmjopen-2018-022510. 41. Jephcott AE. Microbiological diagnosis of gonorrhoea. Genitourin Med 1997;73: 245-52. 42. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19. 43. Whiley DM, Goire N, Lahra MM et al. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother 2012;67:2059-61 44. Department of Health, Health Protection Agency and BASHH Feb 2010. Guidance for gonorrhoea testing in England and Wales. (Available from: http://www.bashh.org/guidelines (2010 HPA guidance on Gonorrhoea testing in England & Wales) (accessed 30 October 2012). 45. Remis RS, Liu J, Loutfy MR Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto. PLoS One. 2016 Jul 8;11(7):e0158090. doi: 10.1371/journal.pone.0158090. eCollection 2016. 46. Филатова Е. Н Аковбян В. А., Дмитриев Г. А., Тихонова Л. И. Культуральный метод диагностики гонореи при проведении скрининга на ИППП./ // ИППП. 2001. - № 2. - С. 20- 25. 47. Sönnichsen N, Müller M. Is the post-therapeutic provocation test in gonorrhea justified? Dermatol Monatsschr. 1973 Oct;159(10):974. 48. Renton A, Filatova E, Ison C A trial of the validity of genital smears and cultures with gonococcal vaccine provocation in diagnosing genital gonorrhoea in women. Int J STD AIDS. 2009 Jan;20(1):24-9. doi: 10.1258/ijsa.2008.008147. 49. Kubanov A, Vorobyev D, Chestkov A et al. Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015). BMC Infect Dis. 2016 Aug 9;16:389. doi: 10.1186/s12879-016-1688-7. 50. Fletcher-Lartey S, Dronavalli M, Alexander K et al. Trends in Antimicrobial Resistance Patterns in Neisseria Gonorrhoeae in Australia and New Zealand: A Meta-analysis and Systematic Review. Antibiotics (Basel). 2019 Oct 23;8(4). pii: E191. doi: 10.3390/antibiotics8040191. 51. Yuan Q, Li Y, Xiu L et al. Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018. Emerg Microbes Infect. 2019;8(1):1546-1549. doi: 10.1080/22221751.2019.1681242. 52. Moran JS, Levine WC. Drugs of choice in the treatment of uncomplicated gonococcal infection. Clin Infect Dis 1995;20(Suppl 1):S47-65. 35 53. Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012;61:590-4. 54. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhoea in adults in the United States. Clin Infect Dis 2007;44:S84-101. 55. Comunián-Carrasco G, Peña-Martí GE, Martí-Carvajal AJ. Antibiotics for treating gonorrhoea in pregnancy. Cochrane Database Syst Rev. 2018 Feb 21;2:CD011167. doi: 10.1002/14651858.CD011167.pub2. 56. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012;56:1273-80. 57. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011;16(14):p11=19833. 58. Bignell C, Unemo M; European STI Guidelines Editorial Board. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013 Feb;24(2):85-92. doi: 10.1177/0956462412472837. 59. European Medicines Agency, Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics 16 November 2018 E M A /7 9 5 3 4 9 /2 0 1 8. 60. Costumbrado J, Ghassemzadeh S. Gonococcal Conjunctivitis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2019-.2019 Feb 15. 61. Bignell C, Fitzgerald M, BASHH Guideline Development Group. UK national guideline for the management of gonorrhoea in adults, 2011. Int J STD AIDS 2011;22:541-7. 62. Kong FYS, Horner P, Unemo M, Hocking JS. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review. J Antimicrob Chemother 2019;74:1157-66. 63. Wise CM, Morris CR, Wasilauskas BL, Salzer WL. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (19851991). Arch Intern Med 1994;154:2690-5. 64. Workowski KA, Bolan GA; Sexually Transmitted Diseases Treatment Guidelines, 2015. Morbidity and Mortality Weekly Report. Recommendations and Reports / Vol. 64 / No. 3 June 5, 2015. https://www.cdc.gov/std/tg2015/tg-2015-print.pdf 65. Забиров К.И. Современные представления о проблеме эпидидимита // Consilium Medicum. 2011. Т. 13. № 7. стр.88-92 36 66. Забиров К.И., Кисина В.И,РазинаС.Е.,ВавиловВ.В. Эпидидимит как осложнение инфекций , передаваемых половым путем // Врач. 2009, январь. С.1619 67. Delavierre D. Orchi-epididymitis Ann Urol (Paris). 2003 Dec;37(6):322-38. 68. Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin-allergic patients: A meta-analysis. Otolaryngol Head Neck Surg 2007;136:340-7. 69. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med 2008;121:572-6. 70. Perry M, Allison BA. Gonorrheal Diseases. Pediatr Rev. 2018 Aug;39(8):427-429. doi: 10.1542/pir.2017-0120. 71. MacDonald N, Mailman T, Desai S. Gonococcal infections in newborns and in adolescents. Adv Exp Med Biol. 2008;609:108-30. doi: 10.1007/978-0-387-73960-1_9. 72. Breslin K, Tuchman L, Hayes KL Sensitivity and Specificity of Empiric Treatment for Sexually Transmitted Infections in a Pediatric Emergency Department. J Pediatr. 2017 Oct;189:48-53. doi: 10.1016/j.jpeds.2017.05.050. Epub 2017 Jun 17. 73. La Ruche G, Goubard A, Bercot B Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012. Euro Surveill. 2014 Aug 28;19(34). pii: 20885. 74. Unemo M, Lahra MM, Cole M et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex Health. 2019 Aug 23. doi: 10.1071/SH19023. 75. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force [Internet].Guirguis-Blake JM, Evans CV, Rushkin M. Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Jan. Report No.: 18- 05242-EF-1. 76. Tan AK. Ophthalmia Neonatorum. N Engl J Med. 2019 Jan 10;380(2):e2. doi: 10.1056/NEJMicm1808613. 77. Ведение больных с инфекциями, передаваемыми половым путем, и урогенитальными инфекциями: Клинические рекомендации. Российское общество дерматовенерологов и косметологов. – М.: Деловой экспресс, 2012. – 112 с. 78. Jin J. Prevention of Gonococcal Eye Infection in Newborns. JAMA. 2019 Jan 29;321(4):414. doi: 10.1001/jama.2018.21434. 79. Zloto O, Gharaibeh A, Mezer E et al. Ophthalmia neonatorum treatment and prophylaxis: IPOSC global study. Graefes Arch Clin Exp Ophthalmol. 2016 Mar;254(3):577-82. doi: 10.1007/s00417- 016-3274-5. Epub 2016 Jan 26. 37 80. European Centre for Disease Prevention and Control (ECDC). Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. Stockholm: ECDC; 2012. p. 1-23. https://www.ecdc.europa.eu/en/publications-data/response-plan-control-and-managethreat-multidrug-resistant-gonorrhoea-europe 81. Okah E, Westheimer EF, Jamison K et al. Frequency of Nucleic Acid Amplification Test Positivity Among Men Who Have Sex With Men Returning for a Test-of-Cure Visit 7 to 30 Days After Treatment of Laboratory-Confirmed Neisseria gonorrhoeae Infection at 2 Public Sexual Health Clinics, New York City, 2013 to 2016. Sex Transm Dis. 2018 Mar;45(3):177-182. doi: 10.1097/OLQ.0000000000000712. 82. Wijers JNAP, van Liere GAFS, Hoebe CJPA Test of cure, retesting and extragenital testing practices for Chlamydia trachomatis and Neisseria gonorrhoeae among general practitioners in different socioeconomic status areas: A retrospective cohort study, 2011-2016. PLoS One. 2018 Mar 14;13(3):e0194351. doi: 10.1371/journal.pone.0194351. eCollection 2018. 83. Hananta IPY, De Vries HJC, van Dam AP Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study. Sex Transm Infect. 2017 Nov;93(7):467-471. doi: 10.1136/sextrans-2017-053147. Epub 2017 Aug 19. 84. Wynn A, Moucheraud C, Moshashane N et al. Using partner notification to address curable sexually transmitted infections in a high HIV prevalence context: a qualitative study about partner notification in Botswana. BMC Public Health. 2019 May 29;19(Suppl 1):606. doi: 10.1186/s12889-019-6813-2. 85. Taleghani S, Joseph-Davey D, West SB Acceptability and efficacy of partner notification for curable sexually transmitted infections in sub-Saharan Africa: A systematic review. Int J STD AIDS. 2019 Mar;30(3):292-303. doi: 10.1177/0956462418803983. Epub 2018 Nov 5. 86. Datta S, Mercer CH, Keeling MJ. et al. Capturing sexual contact patterns in modelling the spread of sexually transmitted infections: Evidence using Natsal-3. PLoS One. 2018 Nov 1;13(11):e0206501. doi: 10.1371/journal.pone.0206501. eCollection 2018.